To receive our monthly eNews as well as event notices and other updates, just enter your email address.
Routine preanesthetic tests cost more than $60 billion every year, but far fewer than 1% reveal pertinent abnormalities relating to the anesthetic or the surgery, according to a 1989 study published in the Canadian Journal of Anesthesia (1989;36:S13-S19).
For that reason, national guidelines recommend minimizing preoperative testing in low-risk, stable patients undergoing non-emergent surgery. The American Society of Anesthesiologists (ASA) released a guideline in 2012 that advised against routine testing, such as labs, chest x-rays and electrocardiograms (EKG). But the ASA suggested a tailored approach for anything with a high risk.
Yet testing remains a common practice. Roughly half of low-risk patients still undergo unnecessary preoperative testing, according to two recent studies (Ann Surg 2012;256:518-528 and Anesth Analg 2011;112:207-212).
An interdisciplinary panel of physicians from around New York City met recently to discuss the appropriate use of pre-op testing at the New York Academy of Medicine. The session, “Why Bother! The Comprehensive Pre-Op Panel,” was organized after the American Board of Internal Medicine (ABIM) Foundation listed preoperative testing in patients undergoing routine surgery as one of five medical services of questionable value.
Preoperative testing has been an accepted part of medicine for more than 150 years since the English physician John Snow wrote about the benefit of examining his patient before administering chloroform. In the 1990s, however, doctors began to ask if these tests made any difference in outcome, and the answer was “we always did it that way,” said Elizabeth Frost, MD, clinical professor of anesthesiology at the Icahn School of Medicine at Mount Sinai, in New York City, who appeared on the panel.
“I’ve heard surgeons say that their administrator orders the tests, that the patient expects to give blood and be tested, that anesthesia will cancel the case if there are no tests, that there’s a legal liability without testing and that they have to support the hospital and labs,” Dr. Frost said.
Dr. Frost is the creator of the PreAnesthetic Assessment, a series of continuing medical education articles (published in Anesthesiology News and online).
The ABIM Foundation’s “Choosing Wisely” campaign, an initiative to reduce the overuse of tests and procedures, created a guideline to help clinicians better understand and deal with the controversial medical services. The framework consists of four points: evidence of harm or little benefit, frequent misuse in practice, that it be measurable and that it be under provider control.
Preoperative testing certainly is measurable and under provider control, but many physicians are unconvinced about the other two aspects, said panelist Deborah Korenstein, MD, editor of ACP Smart Medicine, a publication of the American College of Physicians.
“There is strong evidence that pre-op testing does not change outcomes or surgery cancellation rates for patients undergoing minor procedures like cataract surgery,” Dr. Korenstein told attendees. “Studies have looked for harms that were a direct result of the tests, like bleeding and nerve damage from blood draws; and although they are rare, they are not nonexistent.”
These tests also can have non-physical consequences, such as false-positive results that trigger patient anxiety and even surgical delays, she continued.
So what do all these tests cost? A chest X-ray is $128, EKG is $216, CBC is $156, electrolytes is $626, urinalysis is $85 and a stress test is $2,300, for a grand total of $3,511, according to prices from Dr. Frost’s bill at White Plains Hospital in 2012 and the cost of a stress test at Mount Sinai.
“Pre-op lab and EKG testing should clearly be driven by history, physical and surgical risk only,” said Dr. Frost, a member of the editorial board of Anesthesiology News. “You should do a test only if it can correctly identify abnormalities, if it can change the diagnosis, or if it’s going to change the management plan or outcome. Such tests are very expensive, can cause delays and can come with unforeseen complications.”
Dr. Frost researched policies around the world and found that several other countries shared her views. Germany and Thailand are using preoperative guidelines that reduce unnecessary testing; the United Kingdom believes that there is no evidence of clinical benefit and cost-effectiveness of routine testing; and Canada supports pregnancy tests but discourages nearly all the rest.
Yet the United States has no consensus. After the ASA released its list of indications for preoperative tests, a surgeon from Texas wrote in a peer-reviewed journal that the recommendations lacked clarity, were not specific to ambulatory surgery and were not based on well-designed studies (Adv Surg 2013;47:81-98).
Panelist Tomas Heimann, MD, chief of surgery at James J. Peters VA Medical Center, in New York City, and professor of surgery at Mount Sinai, said the problem is not that preoperative testing is useless, but rather that the wrong tests are often performed.
“Our system is flawed because if a patient has an operation at Montefiore [in New York City] and is now at Mount Sinai with a complication, that information isn’t always provided,” Dr. Heimann said. “We’re doing a lot of tests now that have some usefulness, but a lot of them aren’t really making any difference. If you’re about to operate on a patient to remove his gallbladder, these routine tests aren’t going to help you. It’s critical that we’re doing tests of clinical benefit.”
A System for Reducing Needless Testing
The radiology department at Weill Cornell Medical Center, in New York City, implemented a clinical decision support system that has improved health care by influencing physician choices.
The system was embedded into the department’s electronic ordering system several years ago to assist with real-time decisions. After a specific image or procedure is entered into the machine, a menu will appear and ask for more information. The system then scores the request based on previously applied criteria, and either approves it or suggests another course that is more appropriate.
There are some guidelines that indicate when a physician should do a specific test, but the problem is what they are and how to remember them all in the moment, said Keith Hentel, MD, executive vice chairman and associate professor of radiology at Weill Cornell.
“With the evidence that we’ve incorporated into our clinical practice, it’s now clear that the pre-op chest x-ray is an avoidable test,” Dr. Hentel said. “Clinical decision support is one mechanism that can be used to reduce imaging, and it could be easily applied to other fields. I would encourage individual practices to get started reducing unnecessary testing and then make their results known, because big changes are being made to health care.”
Director of Marketing & Communications
The New York Academy of Medicine
1216 Fifth Avenue
New York, NY 10029
Reporters: to arrange interviews with NYAM medical and urban health experts, contact
Gina Ravosa, Director of Marketing & Communications
(212) 822-7285 / firstname.lastname@example.org
The 2013 Duncan Clark Lecture - The Affordable Care Act on the Verge of Final Success ... and a Nervous Breakdown
Featured Speaker: John E. McDonough, DPH, MPA, Professor of the Practice of Public Health and Director of the Center for Public Health Leadership
Department of Health Policy and Management at the Harvard School of Public Health
December 9, 2013 - On December 2, 2013 NYAM welcomed Dr. John E. McDonough, one of the leading experts on health care reform in the United States, to deliver the 2013 Duncan Clark Lecture at NYAM on “The Affordable Care Act on the Verge of Final Success ... and a Nervous Breakdown.”
Learn more »
This report identifies opportunities that build on both the Patient Protection and Affordable Health Care Act (ACA) and New York’s ongoing efforts toward improving the health of its 19 million residents.
Read press release